The Royal Marsden NHS Foundation Trust is an NHS Foundation Trust which operates the Royal Marsden Hospital facilities on two sites: The trust hopes to raise 45% of its income from private patients and other non-NHS sources in 2016/7 and is trying to raise its income from paying patients from £90m to £100m. According to LaingBuisson it is the most commercially orientated NHS hospital. It increased private patient income by 13% from 2014 to 2016 to £77 million. In 2018-19 it made £121 million through its private patient units, more than a quarter of its total income, and about 18% of all the private healthcare carried out in England by the NHS. This growth was led by imaging and robotic surgery. In 2019-20 50% of the trust’s total revenue, £463 million, came from NHS work. 9% came from Kuwait. Payments from health insurance firms accounted for 16%, and self-pay patients for 2%. The main commercial rival is Leaders in Oncology Care which in 2018 had income of £95 million across its four sites. More information...
According to PR-model, royalmarsden.nhs.uk is ranked 127,247th in multilingual Wikipedia, in particular this website is ranked 74,489th in English Wikipedia.
The website is placed before mythdetector.ge and after brilliantbutcancelled.com in the BestRef global ranking of the most important sources of Wikipedia.